Merck (MRK) Operating Income (2009 - 2026)

Merck (MRK) has 18 years of Operating Income data on file, last reported at -$7.7 billion in Q1 2026.

• Operating Income for Q1 2026 came in at -$7.7 billion, down 411.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.5 billion (down 208.46% YoY), and the FY2025 annual result was $4.7 billion, down 1.22% from the prior year.
• Operating Income slipped to -$7.7 billion in Q1 2026 per MRK's latest filing, from -$2.1 billion in the prior quarter.
• Over five years, Operating Income peaked at $2.9 billion in Q3 2025 and troughed at -$9.4 billion in Q2 2023.
• A 5-year average of -$794.4 million and a median of $10.0 million in 2024 frame the typical range for Operating Income.
• The sharpest annual moves came in 2023 and 2025: Operating Income slumped 3553.51% in 2023, then jumped 28800.0% in 2025.
• A 5-year view of Operating Income shows it stood at -$368.0 million in 2022, then sank by 1519.02% to -$6.0 billion in 2023, then jumped by 105.74% to $342.0 million in 2024, then tumbled by 723.1% to -$2.1 billion in 2025, then slumped by 262.69% to -$7.7 billion in 2026.
• Business Quant data shows MRK's Operating Income at -$7.7 billion in Q1 2026, -$2.1 billion in Q4 2025, and $2.9 billion in Q3 2025.